Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Viatris“
Suchtreffer
Begriffe & Kennungen
Anagrelide Viatris (previously Anagrelide Mylan) · 4.5 · Interaction studies have only been performed in adults.
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.5 · Limited pharmacokinetic and/or pharmacodynamic studies investigating possible interactions between anagrelide
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.5 · Paediatric population
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.5 · • Anagrelide demonstrates some limited inhibitory activity towards CYP1A2 which may present a theoretical pote
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.8 Undesirable effects · 1
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.8 · 48 patients aged 6 through17 years (19 children and 29 adolescents) have received anagrelide for up to 6.5 yea
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.8 · 7 The most commonly reported adverse reactions associated with anagrelide were headache occurring at approxima
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.8 · 8 MedDRA Frequency of adverse reactions System Organ Very Common Uncommon Rare Not known Class common Dyspnoea
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.8 · Adverse reactions arising from clinical studies, post-authorisation safety studies and spontaneous reports are
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.8 · In the later study 3,660 patients who received anagrelide at a mean dose of approximately 2 mg/day were assess
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.8 · MedDRA Frequency of adverse reactions System Organ Very Common Uncommon Rare Not known Class common Blood and
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.8 · Paediatric population
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.8 · Summary of the safety profile
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.8 · The safety of anagrelide has been examined in 4 open label clinical studies. In 3 of the studies 942 patients
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan)
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.1 Therapeutic indications · 1
Eintrag öffnen